ALEC Alector, Inc.

NEUTRAL Impact: 4/10 Institutional Cluster
Horizon weeks Processed 1d 21h ago
Institutional cluster: 5 buyers, 3 sellers (mixed)

Executive Summary

Institutional cluster for ALEC shows 5 active/quant funds adding $6.7M in positions while 3 passive funds trimmed $683K in value (though their positions appreciated). Net accumulation suggests growing institutional interest, but historical calibration on this ticker shows poor track record for bullish calls. The cluster is modest in size relative to market cap (~3.5% of market cap).

Key Financial Metrics

Direction
accumulating
Buy Value
$7.9M
Net Flow
$6.0M

Institutional Positions

Net institutional flow: $6.0M

▲ Buyers (5)

InstitutionActionChangePosition ValueValue Δ
D.E. Shaw ADD +83.1% $2.9M $2.1M
UBS DOUBLED +450.2% $682.0K $624.0K
Two Sigma ADD +38.3% $909.0K $598.0K
Ameriprise Financial DOUBLED +1838.7% $811.0K $791.0K
Barclays DOUBLED +414.4% $2.6M $2.6M

▼ Sellers (3)

InstitutionActionChangePrev ValueValue Δ
T. Rowe Price TRIM -55.2% $7.0K -$357.00
Morgan Stanley TRIM -28.4% $849.0K $436.0K
BofA TRIM -28.4% $481.0K $248.0K

Actionable Insight

Monitor for upcoming catalysts (pipeline data, earnings) that may have driven this accumulation. The cluster is modest and historical signals on ALEC have been unreliable — treat as incremental positive but not a strong conviction signal. Watch for further 13F filings to confirm trend.

Key Facts

  • 5 buyers (D.E. Shaw, UBS, Two Sigma, Ameriprise, Barclays) added $6.7M in value
  • 3 sellers (T. Rowe Price, Morgan Stanley, BofA) trimmed shares but their positions appreciated by $683K
  • Net buying of ~$6.0M represents ~3.5% of ALEC's $169M market cap
  • Buyers are predominantly quant/active managers; sellers are mega-passive funds
  • T. Rowe Price trimmed 55% of its position but the dollar value was negligible

Financial Impact

5 institutions accumulated $6.7M in new positions while 3 institutions reduced holdings by $683K in value (though their positions appreciated). Net buying of approximately $6.0M represents ~3.5% of market cap.

institutional ownershipfloat

Risk Factors

  • 13F reporting lag — positions may have been unwound since quarter-end
  • Low market cap and liquidity risk for ALEC
  • Historical bullish calls on ALEC have underperformed (40% win rate at T+20)

Market Snapshot

Exchange
Nasdaq
Sector
Biological Products, (No Diagnostic Substances)
Analyst Consensus
57% bullish (14 analysts)

Documents Analyzed

This report is based on 1 institutional 13F filing from SEC EDGAR.

DocumentAccession Number
INST-CLUSTER Data (Synthetic)inst-cluster-ALEC-2025-Q3
6 reports for ALEC
Performance horizon
100% Hit rate 3 of 3 directional calls best @ T+60▲ +25.45%Mar 12, 2026
Filters
Rows
Reports for ALEC — sortable, filterable
Type Now
Jun 11, 2026
1d ago
Institutional Cluster
NEUTRAL ★ 4/10
$1.53 awaiting T+1awaiting T+1
Jun 3, 2026
9d ago
Insider Cluster
NEUTRAL ★ 3/10
$1.81 $1.64▼ −9.67%▼ −7.07%
May 7, 2026
5w ago
8-K
BEARISH ★ 6/10
$2.10 $2.05▲ +2.38%▲ +2.61%
Mar 12, 2026
13w ago
S-3
BEARISH ★ 7/10
$2.20 $2.21▼ −0.45%▲ +0.57%
Mar 2, 2026
14w ago
Insider Cluster
BEARISH ★ 5/10
$2.21 $2.11▲ +4.52%▲ +3.61%
Feb 26, 2026
15w ago
Insider Cluster
NEUTRAL ★ 3/10
$2.56 $2.43▼ −5.08%▼ −4.63%
Showing 6 of 6

US Market Status

Market Closed — Opens Mon (46h 47m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access